2024 Q3 Form 10-Q Financial Statement

#000149315224035597 Filed on September 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $704.9K
YoY Change -77.41%
Cost Of Revenue $432.8K
YoY Change -80.57%
Gross Profit $272.1K
YoY Change -69.52%
Gross Profit Margin 38.6%
Selling, General & Admin $3.527M
YoY Change 28.39%
% of Gross Profit 1296.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.527M
YoY Change 28.39%
Operating Profit -$3.255M
YoY Change 75.51%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$965.6K
YoY Change -195.8%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$4.221M
YoY Change 398.46%
Net Earnings / Revenue -598.77%
Basic Earnings Per Share -$1.91
Diluted Earnings Per Share -$1.91
COMMON SHARES
Basic Shares Outstanding 2.659M shares
Diluted Shares Outstanding 2.206M shares

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.711M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $1.661M
Prepaid Expenses
Receivables $258.3K
Other Receivables
Total Short-Term Assets $21.18M
YoY Change 362.22%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.001M
YoY Change 0.0%
TOTAL ASSETS
Total Short-Term Assets $21.18M
Total Long-Term Assets $2.001M
Total Assets $23.19M
YoY Change 252.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.932M
YoY Change -18.97%
Accrued Expenses $4.168M
YoY Change -19.81%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.75M
YoY Change -40.99%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $13.75M
Total Long-Term Liabilities
Total Liabilities $13.75M
YoY Change -44.91%
SHAREHOLDERS EQUITY
Retained Earnings -$171.6M
YoY Change 12.46%
Common Stock $180.9M
YoY Change 34.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $9.438M
YoY Change
Total Liabilities & Shareholders Equity $23.19M
YoY Change 252.14%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$4.221M
YoY Change 398.46%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$72.65K
YoY Change -127.19%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.615M
YoY Change -368.71%
NET CHANGE
Cash From Operating Activities -$72.65K
Cash From Investing Activities
Cash From Financing Activities $1.615M
Net Change In Cash $1.482M
YoY Change -521.14%
FREE CASH FLOW
Cash From Operating Activities -$72.65K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2024Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001674440
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
usd
CY2024Q3 YYAI Loss On Conversion Of Accounts Payable To Common Stock
LossOnConversionOfAccountsPayableToCommonStock
usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2023Q3 YYAI Stock Issued During Period Value Cashless Exercise Of Warrants
StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
usd
CY2024Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
usd
CY2024Q3 YYAI Stock Issued During Period Value Fractional Adjustment In Reverse Split
StockIssuedDuringPeriodValueFractionalAdjustmentInReverseSplit
usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2023Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2024Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2024Q3 YYAI Settlement Expense
SettlementExpense
usd
CY2024Q3 YYAI Loss On Settlement Of Accounts Payable
LossOnSettlementOfAccountsPayable
usd
CY2023Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2023Q3 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
usd
CY2024Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2024Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q3 YYAI Shares Issued For Contingent Consideration
SharesIssuedForContingentConsideration
usd
CY2024Q3 dei Document Type
DocumentType
10-Q
CY2024Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q3 dei Document Period End Date
DocumentPeriodEndDate
2024-07-31
CY2024Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q3 dei Entity File Number
EntityFileNumber
01-41423
CY2024Q3 dei Entity Registrant Name
EntityRegistrantName
CONNEXA SPORTS TECHNOLOGIES INC.
CY2024Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1789640
CY2024Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
2709 NORTH ROLLING ROAD
CY2024Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 138
CY2024Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
WINDSOR MILL
CY2024Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2024Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21244
CY2024Q3 dei City Area Code
CityAreaCode
(443)
CY2024Q3 dei Local Phone Number
LocalPhoneNumber
407-7564
CY2024Q3 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2024Q3 dei Trading Symbol
TradingSymbol
YYAI
CY2024Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q3 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.001
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6435454 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1711283 usd
CY2024Q3 us-gaap Short Term Investments
ShortTermInvestments
16500000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
258273 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
1660847 usd
CY2024Q3 YYAI Prepaid Inventory Current
PrepaidInventoryCurrent
884266 usd
CY2024Q2 YYAI Prepaid Inventory Current
PrepaidInventoryCurrent
810978 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
169731 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
21184400 usd
CY2024Q3 us-gaap Other Receivables
OtherReceivables
2000000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1000 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
2001000 usd
CY2024Q3 us-gaap Assets
Assets
23185400 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4932295 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4167750 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5279 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
316920 usd
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
255648 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
13747072 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
12022810 usd
CY2024Q3 us-gaap Liabilities
Liabilities
13747072 usd
CY2024Q2 us-gaap Liabilities
Liabilities
12022810 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2659149 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2659149 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1828541 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1828541 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
2659 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
1828 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
180920634 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
176801473 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-171607773 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-167387028 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
122808 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
183541 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
9438328 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
9599814 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23185400 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21622624 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
272121 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
892749 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
146137 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
242353 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3381179 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2505060 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
3527316 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
2747413 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3255195 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1854664 usd
CY2023Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
777192 usd
CY2023Q3 YYAI Loss On Conversion Of Accounts Payable To Common Stock
LossOnConversionOfAccountsPayableToCommonStock
289980 usd
CY2024Q3 YYAI Gain Loss On Change In Fair Value Of Derivatives Liability
GainLossOnChangeInFairValueOfDerivativesLiability
154 usd
CY2023Q3 YYAI Gain Loss On Change In Fair Value Of Derivatives Liability
GainLossOnChangeInFairValueOfDerivativesLiability
2144554 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
965704 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
69483 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-965550 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1007899 usd
CY2024Q3 YYAI Income Loss From Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4220745 usd
CY2023Q3 YYAI Income Loss From Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-846765 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-4220745 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-846765 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-60733 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-27020 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4281478 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-873785 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.91
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.91
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.93
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.93
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2205834 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2205834 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
438354 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
438354 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-18613761 usd
CY2023Q3 YYAI Stock Issued During Period Value Accounts Payable
StockIssuedDuringPeriodValueAccountsPayable
559980 usd
CY2023Q3 YYAI Stock Issued During Period Value Satisfaction Of Profit Guarantee On Note Payable
StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable
558294 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-27020 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-27020 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-846765 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-18369272 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
9599814 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
9599814 usd
CY2024Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
2501816 usd
CY2024Q3 YYAI Stock Issued During Period Exercise Of Warrants Value
StockIssuedDuringPeriodExerciseOfWarrantsValue
1618176 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-60733 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-4220745 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
9438328 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
9438328 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-4220745 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-846765 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
115072 usd
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
154 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2144554 usd
CY2024Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2501816 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
777192 usd
CY2023Q3 YYAI Settlement Expense
SettlementExpense
558294 usd
CY2023Q3 YYAI Loss On Settlement Of Accounts Payable
LossOnSettlementOfAccountsPayable
289980 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-17243 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
265992 usd
CY2024Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
51651 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-852848 usd
CY2024Q3 YYAI Increase Decrease In Prepaid Inventory
IncreaseDecreaseInPrepaidInventory
73288 usd
CY2023Q3 YYAI Increase Decrease In Prepaid Inventory
IncreaseDecreaseInPrepaidInventory
197429 usd
CY2024Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-28140 usd
CY2023Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1316 usd
CY2024Q3 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
703311 usd
CY2023Q3 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
255199 usd
CY2024Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
346397 usd
CY2023Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
326550 usd
CY2024Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
676285 usd
CY2023Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
16135 usd
CY2024Q3 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
4148099 usd
CY2023Q3 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
1113963 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-72646 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
267198 usd
CY2024Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1618176 usd
CY2024Q3 us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-3218 usd
CY2023Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
298834 usd
CY2023Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
302168 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1614958 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-601002 usd
CY2024Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-60734 usd
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-17997 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1481578 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-351800 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
229705 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
202095 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1711283 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-149705 usd
CY2024Q3 us-gaap Interest Paid Net
InterestPaidNet
113915 usd
CY2023Q3 YYAI Shares Issued For Contingent Consideration
SharesIssuedForContingentConsideration
270000 usd
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10 reverse stock split
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-20 reverse stock split
CY2024Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1925000 shares
CY2023Q4 YYAI Impact Of Israel And Hamas Conflict Description
ImpactOfIsraelAndHamasConflictDescription
the Central Bank of Israel announced its intent to sell up to $30 billion order to protect the New Israeli Shekel (“NIS”) from collapse, however despite the foregoing announcement the NIS weakened to approximately 3.92 NIS for one US dollar as of the same day. In addition, on October 9, 2023, the Tel Aviv-35 stock index of blue-chip companies dropped by 6.4% whereas the benchmark TA-125 index fell by 6.2%.
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-171607773 usd
CY2024Q3 us-gaap Discontinued Operation Equity Method Investment Retained After Disposal Ownership Interest After Disposal
DiscontinuedOperationEquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposal
0.20 pure
CY2024Q3 us-gaap Alternative Investment
AlternativeInvestment
165000 usd
CY2024Q3 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zTwIZZ8DYG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_840_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_z3uqOQ2xBuSh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Financial Statement Reclassification</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with the current year presentation and had no effect on the Company’s balance sheet, net loss, shareholders’ deficit or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
28000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
40000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1845255 usd
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
995533 usd
CY2024Q3 YYAI Component Replacement Parts
ComponentReplacementParts
-240290 usd
CY2024Q2 YYAI Component Replacement Parts
ComponentReplacementParts
770737 usd
CY2024Q3 YYAI Capitalized Duty And Freight
CapitalizedDutyAndFreight
90882 usd
CY2024Q2 YYAI Capitalized Duty And Freight
CapitalizedDutyAndFreight
26171 usd
CY2024Q3 us-gaap Inventory Adjustments
InventoryAdjustments
35000 usd
CY2024Q2 us-gaap Inventory Adjustments
InventoryAdjustments
183245 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
1660847 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
1609196 usd
CY2024Q3 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2024Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zYLuPb9ILetl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Concentration of Credit Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations or financial condition. See Note 4 for further details on the Company’s concentration of credit risk as well as other risks and uncertainties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
5279 usd
CY2024Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
154 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4895582 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
153677 usd
CY2024Q3 YYAI Impairment Of Intangible Asset Finitelived
ImpairmentOfIntangibleAssetFinitelived
4740905 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
4895582 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
153677 usd
CY2024Q2 YYAI Impairment Of Intangible Asset Finitelived
ImpairmentOfIntangibleAssetFinitelived
4740905 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2024Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1465142 usd
CY2024Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1304363 usd
CY2024Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1177777 usd
CY2024Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1022751 usd
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
73500 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
37212 usd
CY2024Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1451331 usd
CY2024Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1041046 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4167750 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3405372 usd
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
3197335.65 usd
CY2024Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3000000 usd
CY2024Q1 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
499584 shares
CY2024Q1 us-gaap Common Stock Convertible Conversion Price Increase
CommonStockConvertibleConversionPriceIncrease
6.40
CY2024Q1 us-gaap Common Stock Convertible Conversion Price Decrease
CommonStockConvertibleConversionPriceDecrease
6.40
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.20
CY2024Q1 us-gaap Guaranteed Benefit Liability Net
GuaranteedBenefitLiabilityNet
6000000 usd
CY2024Q1 us-gaap Escrow Deposit
EscrowDeposit
2000000 usd
CY2024Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6000000 usd
CY2024Q2 us-gaap Escrow Deposit
EscrowDeposit
2000000 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2659149 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2659149 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1828541 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1828541 shares
CY2024Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
830608 shares
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10 usd
CY2024Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
214128 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
505680 shares
CY2024Q3 us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
110790 shares
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
189718 shares
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
188 usd
CY2023Q3 YYAI Stock Issued During Period Shares Issued Settlement Of Accounts Payable
StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable
67500 shares
CY2023Q3 YYAI Stock Issued During Period Shares Issued Settlement
StockIssuedDuringPeriodSharesIssuedSettlement
1350 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
27000 shares
CY2023Q3 YYAI Stock Issued During Period Shares Issued Profit Guarantee On Note
StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote
93680 shares
CY2024Q3 us-gaap Payments For Rent
PaymentsForRent
2300 usd
CY2023Q3 us-gaap Payments For Rent
PaymentsForRent
1969 usd
CY2022Q1 YYAI Fair Value Of Common Stock
FairValueOfCommonStock
1334000 usd
CY2022Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
14960 shares
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
418455 usd
CY2024Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1925000 shares

Files In Submission

Name View Source Status
0001493152-24-035597-index-headers.html Edgar Link pending
0001493152-24-035597-index.html Edgar Link pending
0001493152-24-035597.txt Edgar Link pending
0001493152-24-035597-xbrl.zip Edgar Link pending
ex3-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
yyai-20240731.xsd Edgar Link pending
yyai-20240731_def.xml Edgar Link unprocessable
yyai-20240731_pre.xml Edgar Link unprocessable
yyai-20240731_lab.xml Edgar Link unprocessable
yyai-20240731_cal.xml Edgar Link unprocessable